Highly Sensitized Candidates Remain at Risk for Microvascular Inflammation Even When Donor-specific Antibody Is Avoided: A Matched Cohort Study.

Amogh AgrawalSuryanarayanan BalakrishnanManish J GandhiMariam P AlexanderLynn CornellAndrew J BentallAleksandra KuklaMark StegallCarrie A Schinstock

Published in: Transplantation (2024)

Highly sensitized transplant recipients have a high incidence of persistent and progressive MVI, even without DSA. The mechanisms underlying these histologic features needs to be elucidated, but this information is important to consider when making decisions about transplantation among highly sensitized individuals.

Keyphrases

oxidative stress
multiple sclerosis
risk factors
stem cells
health information
cell therapy
mesenchymal stem cells
social media